健脾活血益肾汤治疗慢性肾脏病3期合并颈动脉粥样硬化临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R543.4

基金项目:

浙江省中医药科技计划项目(2019ZA118)


Clinical Study on Jianpi Huoxue Yishen Tang on Stage 3 Chronic Kidney Disease Complicated with Carotid Atherosclerosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察健脾活血益肾汤治疗慢性肾脏病3 期合并颈动脉粥样硬化的临床疗效及对炎症因子的影响。方法:采用随机数字表法将110 例慢性肾脏病3 期合并颈动脉粥样硬化患者分为观察组与对照组各55 例。对照组采用肾衰宁治疗,观察组在对照组基础上联合健脾活血益肾汤治疗。比较2 组临床疗效及不良反应、高钾血症发生率;比较2 组治疗前后血清炎症因子水平、肾功能指标、颈动脉超声指标、中医证侯积分及血钾浓度。结果:治疗后,观察组总有效率为96.38%,高于对照组83.26%(P<0.05)。治疗后,2 组白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP) 水平均较治疗前降低(P<0.05),观察组炎症因子水平低于对照组(P<0.05)。2 组血尿素氮(BUN)、血肌酐(SCr) 水平较治疗前降低(P<0.05),内生肌酐清除率(CCr) 水平升高(P<0.05),观察组肾功能指标改善优于对照组(P<0.05)。治疗后,2 组斑块数目、颈动脉斑块Crouse 积分、中医证候积分、颈动脉内膜中层厚度(CIMT) 较治疗前降低(P<0.05),血钾浓度升高(P<0.05),观察组上述指标改善优于对照组(P<0.05)。观察组不良反应发生率、高钾血症发生率低于对照组,但差异无统计学意义(P>0.05)。结论:健脾活血益肾汤治疗慢性肾脏病3 期合并颈动脉粥样硬化疗效确切,能有效改善患者肾功能,减少炎性反应和颈动脉粥样硬化斑块,安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of Jianpi Huoxue Yishen tang on stage 3 chronic kidney disease complicated with carotid atherosclerosis and its effect on inflammatory factors. Methods: A total of 110 cases of patients with stage 3 chronic kidney disease complicated with carotid atherosclerosis were selected and divided into the observation group and the control group according to the random number table method, with 55 cases in each group. The control group was treated with Shenshuaining,and the observation group was additionally treated with Jianpi Huoxue Yishen tang based on the treatment of the control group. The clinical effects,incidence of adverse reactions and incidence of hyperkalemia in the two groups were compared between the two groups;before and after treatment,the levels of serum inflammatory factors, indexes of lung function, indexes of carotid artery ultrasound, Chinese medicine syndrome scores and levels of serum potassium were compared between the two groups. Results: After treatment, the total effective rate was 96.38% in the observation group, higher than that of 83.26% in the control group(P<0.05). After treatment,the levels of interleukin-6(IL-6),tumor necrosis factor-α(TNF-α) and C-reactive protein(CRP) in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of inflammatory factors in the observation group were lower than those in the control group(P<0.05). The levels of blood urea nitrogen(BUN) and serum creatinine (SCr) were decreased when compared with those before treatment(P<0.05),and the levels of creatinine clearance rate(CCr) were increased(P<0.05), and the improvement in indexes of kidney function was better than that in the control group(P<0.05). After treatment, the numbers of plaque, Crouse carotid plaque scores and Chinese medicine syndrome scores and carotid artery intima- media thickness(CIMT) in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of serum potassium were increased(P<0.05),and the improvement in the above indexes in the observation group was better than that in the control group(P<0.05). The incidence of adverse reactions and incidence of hyperkalemia in the observation group were lower than those in the control group, there being no significance in the difference(P>0.05). Conclusion:The therapy of Jianpi Huoxue Yishen tang has a definite curative effect on stage 3 chronic kidney disease complicated with carotid atherosclerosis, which can effectively improve the kidney function of patients,decrease the inflammatory responses and reduce the carotid atherosclerotic plaque,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

张怡,陈妙,张倩倩,欧阳凌霞.健脾活血益肾汤治疗慢性肾脏病3期合并颈动脉粥样硬化临床研究[J].新中医,2022,54(19):110-115

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-10-08
  • 出版日期: